Publicacións en colaboración con investigadores/as de Cleveland Clinic (17)

2024

  1. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 1, pp. 60-72

  2. Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

    European Journal of Heart Failure

2023

  1. Donor heart selection: Evidence-based guidelines for providers

    Journal of Heart and Lung Transplantation, Vol. 42, Núm. 1, pp. 7-29

  2. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 5, pp. e450-e452

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

2020

  1. International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients

    JACC: Heart Failure, Vol. 8, Núm. 3, pp. 212-222

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

  2. Prevalence of Medication Nonadherence to Co-medication Compared to Immunosuppressants in Heart Transplant Recipients: Findings From the International Cross-sectional BRIGHT Study

    Clinical Therapeutics, Vol. 41, Núm. 1, pp. 130-136

2018

  1. Donor polymorphisms in genes related to B-cell biology associated with antibody-mediated rejection after heart transplantation

    Circulation Journal, Vol. 82, Núm. 5, pp. 1351-1359

  2. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 4, pp. 477-485

  3. The management of antibodies in heart transplantation: An ISHLT consensus document

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 5, pp. 537-547

  4. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study

    Catheterization and Cardiovascular Interventions, Vol. 91, Núm. 3, pp. 435-443

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

  2. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management – Findings from the International BRIGHT Study

    Heart and Lung, Vol. 46, Núm. 5, pp. 351-356

2013

  1. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: Insights from a large multicenter registry

    Journal of the American College of Cardiology, Vol. 62, Núm. 17, pp. 1552-1562

2011

  1. Report from a consensus conference on antibody-mediated rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 30, Núm. 3, pp. 252-269

2010

  1. The international society of heart and lung transplantation guidelines for the care of heart transplant recipients

    Journal of Heart and Lung Transplantation